Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells

Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proc. Natl. Acad. Sci. U.S.A.; (United States) 1987-01, Vol.84 (1), p.223-227
Hauptverfasser: Larsson, Lars-Gunnar, Gray, Harry E., Tötterman, Thomas, Pettersson, Ulf, Nilsson, Kenneth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 227
container_issue 1
container_start_page 223
container_title Proc. Natl. Acad. Sci. U.S.A.; (United States)
container_volume 84
creator Larsson, Lars-Gunnar
Gray, Harry E.
Tötterman, Thomas
Pettersson, Ulf
Nilsson, Kenneth
description Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.
doi_str_mv 10.1073/pnas.84.1.223
format Article
fullrecord <record><control><sourceid>jstor_osti_</sourceid><recordid>TN_cdi_jstor_primary_28981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>28981</jstor_id><sourcerecordid>28981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4243-76e8b2d10bf207ed16737803e80bd24af21f635903e2d06e88dea00959d25e0c3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EKkNhyQaBZCHBLoMfeTgLFihtodKgIgELVpbHuZlxydip7VSdPT8chwmjsmFly-c79-GD0HNKlpRU_N1gVViKfEmXjPEHaEFJTbMyr8lDtCCEVZnIWf4YPQnhmhBSF4KcoBNO6prVfIF-nXkVotGq7_f40moPKkCLz-8GDyEYZ7Hr8OcfDVa2xRdXX_EX76JzVrsNWAi4Hb2xG2wsvjXRO3xmug482GhUnN3N1jtrNF7td8PW6X2c7jD-hJ1RuIG-D0_Ro071AZ7N5yn6fnH-rfmUra4-XjYfVplOK_CsKkGsWUvJumOkgpaWFa8E4SDIumW56hjtSl7U6YW1JMGiBTWtXLesAKL5KXp_qDuM6x20Oo3pVS8Hb3bK76VTRv6rWLOVG3crOclpVST_64PfpS-TQZsIequdtaCjLEpSVIIl6O3cxLubEUKUOxN0WlNZcGOQNK8oq_5Uyw6g9i4ED91xEErkFK2copUil1SmaBP_6v70R3rOMukvZ32y_VXv2d_8R5bd2PcR7mLiXhy46xCdP4JM1ILy30ePwc0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14712775</pqid></control><display><type>article</type><title>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Larsson, Lars-Gunnar ; Gray, Harry E. ; Tötterman, Thomas ; Pettersson, Ulf ; Nilsson, Kenneth</creator><creatorcontrib>Larsson, Lars-Gunnar ; Gray, Harry E. ; Tötterman, Thomas ; Pettersson, Ulf ; Nilsson, Kenneth ; University Hospital, Uppsala, Sweden</creatorcontrib><description>Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.84.1.223</identifier><identifier>PMID: 3099293</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>550601 - Medicine- Unsealed Radionuclides in Diagnostics ; 560300 - Chemicals Metabolism &amp; Toxicology ; Actins - genetics ; ANIMAL CELLS ; AZINES ; B cell leukemia ; B lymphocytes ; BIOLOGICAL EFFECTS ; CARCINOGENS ; CELL DIFFERENTIATION ; Cell Differentiation - drug effects ; Cell growth ; Cell Line ; Cell lines ; Cellular differentiation ; Cellular immunity ; DISEASES ; DNA Replication ; ESTERS ; GENE REGULATION ; GENES ; GLOBULINS ; HEMIC DISEASES ; HETEROCYCLIC COMPOUNDS ; Humans ; HYDROXY COMPOUNDS ; IMMUNOASSAY ; Immunoglobulin M - analysis ; Immunoglobulin mu-Chains - genetics ; IMMUNOGLOBULINS ; IMMUNOLOGY ; ISOTOPE APPLICATIONS ; LABELLED COMPOUNDS ; LEUKEMIA ; Leukemia, Lymphoid - genetics ; Leukemia, Lymphoid - immunology ; Leukemia, Lymphoid - pathology ; Lymphocytes - immunology ; Messenger RNA ; NEOPLASMS ; NUCLEOSIDES ; NUCLEOTIDES ; ONCOGENES ; ORGANIC COMPOUNDS ; ORGANIC NITROGEN COMPOUNDS ; PHORBOL ESTERS ; Plasma cells ; PROTEINS ; Proto-Oncogenes ; PYRIMIDINES ; RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT ; RADIOASSAY ; RADIOIMMUNOASSAY ; RADIOIMMUNOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; RIBOSIDES ; RNA ; RNA, Messenger - genetics ; T lymphocytes ; Tetradecanoylphorbol Acetate - pharmacology ; THYMIDINE ; TRACER TECHNIQUES ; Transcription, Genetic ; TRITIUM COMPOUNDS ; TUMOR CELLS ; URACILS ; URIDINE</subject><ispartof>Proc. Natl. Acad. Sci. U.S.A.; (United States), 1987-01, Vol.84 (1), p.223-227</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4243-76e8b2d10bf207ed16737803e80bd24af21f635903e2d06e88dea00959d25e0c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/84/1.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/28981$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/28981$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3099293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/5605782$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Larsson, Lars-Gunnar</creatorcontrib><creatorcontrib>Gray, Harry E.</creatorcontrib><creatorcontrib>Tötterman, Thomas</creatorcontrib><creatorcontrib>Pettersson, Ulf</creatorcontrib><creatorcontrib>Nilsson, Kenneth</creatorcontrib><creatorcontrib>University Hospital, Uppsala, Sweden</creatorcontrib><title>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</title><title>Proc. Natl. Acad. Sci. U.S.A.; (United States)</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.</description><subject>550601 - Medicine- Unsealed Radionuclides in Diagnostics</subject><subject>560300 - Chemicals Metabolism &amp; Toxicology</subject><subject>Actins - genetics</subject><subject>ANIMAL CELLS</subject><subject>AZINES</subject><subject>B cell leukemia</subject><subject>B lymphocytes</subject><subject>BIOLOGICAL EFFECTS</subject><subject>CARCINOGENS</subject><subject>CELL DIFFERENTIATION</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell growth</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Cellular differentiation</subject><subject>Cellular immunity</subject><subject>DISEASES</subject><subject>DNA Replication</subject><subject>ESTERS</subject><subject>GENE REGULATION</subject><subject>GENES</subject><subject>GLOBULINS</subject><subject>HEMIC DISEASES</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>Humans</subject><subject>HYDROXY COMPOUNDS</subject><subject>IMMUNOASSAY</subject><subject>Immunoglobulin M - analysis</subject><subject>Immunoglobulin mu-Chains - genetics</subject><subject>IMMUNOGLOBULINS</subject><subject>IMMUNOLOGY</subject><subject>ISOTOPE APPLICATIONS</subject><subject>LABELLED COMPOUNDS</subject><subject>LEUKEMIA</subject><subject>Leukemia, Lymphoid - genetics</subject><subject>Leukemia, Lymphoid - immunology</subject><subject>Leukemia, Lymphoid - pathology</subject><subject>Lymphocytes - immunology</subject><subject>Messenger RNA</subject><subject>NEOPLASMS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ONCOGENES</subject><subject>ORGANIC COMPOUNDS</subject><subject>ORGANIC NITROGEN COMPOUNDS</subject><subject>PHORBOL ESTERS</subject><subject>Plasma cells</subject><subject>PROTEINS</subject><subject>Proto-Oncogenes</subject><subject>PYRIMIDINES</subject><subject>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</subject><subject>RADIOASSAY</subject><subject>RADIOIMMUNOASSAY</subject><subject>RADIOIMMUNOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RIBOSIDES</subject><subject>RNA</subject><subject>RNA, Messenger - genetics</subject><subject>T lymphocytes</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>THYMIDINE</subject><subject>TRACER TECHNIQUES</subject><subject>Transcription, Genetic</subject><subject>TRITIUM COMPOUNDS</subject><subject>TUMOR CELLS</subject><subject>URACILS</subject><subject>URIDINE</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhS0EKkNhyQaBZCHBLoMfeTgLFihtodKgIgELVpbHuZlxydip7VSdPT8chwmjsmFly-c79-GD0HNKlpRU_N1gVViKfEmXjPEHaEFJTbMyr8lDtCCEVZnIWf4YPQnhmhBSF4KcoBNO6prVfIF-nXkVotGq7_f40moPKkCLz-8GDyEYZ7Hr8OcfDVa2xRdXX_EX76JzVrsNWAi4Hb2xG2wsvjXRO3xmug482GhUnN3N1jtrNF7td8PW6X2c7jD-hJ1RuIG-D0_Ro071AZ7N5yn6fnH-rfmUra4-XjYfVplOK_CsKkGsWUvJumOkgpaWFa8E4SDIumW56hjtSl7U6YW1JMGiBTWtXLesAKL5KXp_qDuM6x20Oo3pVS8Hb3bK76VTRv6rWLOVG3crOclpVST_64PfpS-TQZsIequdtaCjLEpSVIIl6O3cxLubEUKUOxN0WlNZcGOQNK8oq_5Uyw6g9i4ED91xEErkFK2copUil1SmaBP_6v70R3rOMukvZ32y_VXv2d_8R5bd2PcR7mLiXhy46xCdP4JM1ILy30ePwc0</recordid><startdate>19870101</startdate><enddate>19870101</enddate><creator>Larsson, Lars-Gunnar</creator><creator>Gray, Harry E.</creator><creator>Tötterman, Thomas</creator><creator>Pettersson, Ulf</creator><creator>Nilsson, Kenneth</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>OTOTI</scope><scope>5PM</scope></search><sort><creationdate>19870101</creationdate><title>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</title><author>Larsson, Lars-Gunnar ; Gray, Harry E. ; Tötterman, Thomas ; Pettersson, Ulf ; Nilsson, Kenneth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4243-76e8b2d10bf207ed16737803e80bd24af21f635903e2d06e88dea00959d25e0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>550601 - Medicine- Unsealed Radionuclides in Diagnostics</topic><topic>560300 - Chemicals Metabolism &amp; Toxicology</topic><topic>Actins - genetics</topic><topic>ANIMAL CELLS</topic><topic>AZINES</topic><topic>B cell leukemia</topic><topic>B lymphocytes</topic><topic>BIOLOGICAL EFFECTS</topic><topic>CARCINOGENS</topic><topic>CELL DIFFERENTIATION</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell growth</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Cellular differentiation</topic><topic>Cellular immunity</topic><topic>DISEASES</topic><topic>DNA Replication</topic><topic>ESTERS</topic><topic>GENE REGULATION</topic><topic>GENES</topic><topic>GLOBULINS</topic><topic>HEMIC DISEASES</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>Humans</topic><topic>HYDROXY COMPOUNDS</topic><topic>IMMUNOASSAY</topic><topic>Immunoglobulin M - analysis</topic><topic>Immunoglobulin mu-Chains - genetics</topic><topic>IMMUNOGLOBULINS</topic><topic>IMMUNOLOGY</topic><topic>ISOTOPE APPLICATIONS</topic><topic>LABELLED COMPOUNDS</topic><topic>LEUKEMIA</topic><topic>Leukemia, Lymphoid - genetics</topic><topic>Leukemia, Lymphoid - immunology</topic><topic>Leukemia, Lymphoid - pathology</topic><topic>Lymphocytes - immunology</topic><topic>Messenger RNA</topic><topic>NEOPLASMS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ONCOGENES</topic><topic>ORGANIC COMPOUNDS</topic><topic>ORGANIC NITROGEN COMPOUNDS</topic><topic>PHORBOL ESTERS</topic><topic>Plasma cells</topic><topic>PROTEINS</topic><topic>Proto-Oncogenes</topic><topic>PYRIMIDINES</topic><topic>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</topic><topic>RADIOASSAY</topic><topic>RADIOIMMUNOASSAY</topic><topic>RADIOIMMUNOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RIBOSIDES</topic><topic>RNA</topic><topic>RNA, Messenger - genetics</topic><topic>T lymphocytes</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>THYMIDINE</topic><topic>TRACER TECHNIQUES</topic><topic>Transcription, Genetic</topic><topic>TRITIUM COMPOUNDS</topic><topic>TUMOR CELLS</topic><topic>URACILS</topic><topic>URIDINE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Larsson, Lars-Gunnar</creatorcontrib><creatorcontrib>Gray, Harry E.</creatorcontrib><creatorcontrib>Tötterman, Thomas</creatorcontrib><creatorcontrib>Pettersson, Ulf</creatorcontrib><creatorcontrib>Nilsson, Kenneth</creatorcontrib><creatorcontrib>University Hospital, Uppsala, Sweden</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>OSTI.GOV</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proc. Natl. Acad. Sci. U.S.A.; (United States)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Larsson, Lars-Gunnar</au><au>Gray, Harry E.</au><au>Tötterman, Thomas</au><au>Pettersson, Ulf</au><au>Nilsson, Kenneth</au><aucorp>University Hospital, Uppsala, Sweden</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</atitle><jtitle>Proc. Natl. Acad. Sci. U.S.A.; (United States)</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1987-01-01</date><risdate>1987</risdate><volume>84</volume><issue>1</issue><spage>223</spage><epage>227</epage><pages>223-227</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>3099293</pmid><doi>10.1073/pnas.84.1.223</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proc. Natl. Acad. Sci. U.S.A.; (United States), 1987-01, Vol.84 (1), p.223-227
issn 0027-8424
1091-6490
language eng
recordid cdi_jstor_primary_28981
source Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects 550601 - Medicine- Unsealed Radionuclides in Diagnostics
560300 - Chemicals Metabolism & Toxicology
Actins - genetics
ANIMAL CELLS
AZINES
B cell leukemia
B lymphocytes
BIOLOGICAL EFFECTS
CARCINOGENS
CELL DIFFERENTIATION
Cell Differentiation - drug effects
Cell growth
Cell Line
Cell lines
Cellular differentiation
Cellular immunity
DISEASES
DNA Replication
ESTERS
GENE REGULATION
GENES
GLOBULINS
HEMIC DISEASES
HETEROCYCLIC COMPOUNDS
Humans
HYDROXY COMPOUNDS
IMMUNOASSAY
Immunoglobulin M - analysis
Immunoglobulin mu-Chains - genetics
IMMUNOGLOBULINS
IMMUNOLOGY
ISOTOPE APPLICATIONS
LABELLED COMPOUNDS
LEUKEMIA
Leukemia, Lymphoid - genetics
Leukemia, Lymphoid - immunology
Leukemia, Lymphoid - pathology
Lymphocytes - immunology
Messenger RNA
NEOPLASMS
NUCLEOSIDES
NUCLEOTIDES
ONCOGENES
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
PHORBOL ESTERS
Plasma cells
PROTEINS
Proto-Oncogenes
PYRIMIDINES
RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT
RADIOASSAY
RADIOIMMUNOASSAY
RADIOIMMUNOLOGY
RADIOLOGY AND NUCLEAR MEDICINE
RIBOSIDES
RNA
RNA, Messenger - genetics
T lymphocytes
Tetradecanoylphorbol Acetate - pharmacology
THYMIDINE
TRACER TECHNIQUES
Transcription, Genetic
TRITIUM COMPOUNDS
TUMOR CELLS
URACILS
URIDINE
title Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T02%3A50%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drastically%20Increased%20Expression%20of%20MYC%20and%20FOS%20Protooncogenes%20during%20in%20vitro%20Differentiation%20of%20Chronic%20Lymphocytic%20Leukemia%20Cells&rft.jtitle=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.;%20(United%20States)&rft.au=Larsson,%20Lars-Gunnar&rft.aucorp=University%20Hospital,%20Uppsala,%20Sweden&rft.date=1987-01-01&rft.volume=84&rft.issue=1&rft.spage=223&rft.epage=227&rft.pages=223-227&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.84.1.223&rft_dat=%3Cjstor_osti_%3E28981%3C/jstor_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14712775&rft_id=info:pmid/3099293&rft_jstor_id=28981&rfr_iscdi=true